By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Phase Bioscience, Inc. 

Research Triangle Park  North Carolina    U.S.A.
Phone: 919-544-6177 Fax:



Company News
Phase Bioscience, Inc. Announces Positive Clinical Results with its Once Weekly GLP-1 Analogue, Glymera™ for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes 11/15/2011 7:25:19 AM
Craig Rosen, Ph.D., Biopharmaceutical Development Expert, Joins Phase Bioscience, Inc. as Executive Chairman 10/9/2008 9:30:55 AM
Phase Bioscience, Inc. Licenses Key Patent Portfolio, Adds Expert in Protein Engineering IP Protection 9/23/2008 8:24:10 AM
Leading Protein Engineering Executive Joins Phase Bioscience, Inc. as CEO 4/15/2008 8:29:12 AM
Phase Bioscience, Inc. Secures Funding Resources and Laboratory Space 3/12/2008 9:51:23 AM
Phase Bioscience, Inc. Announces New Collaboration with Centocor Research And Development, Inc. 1/3/2008 9:24:32 AM
Phase Bioscience, Inc. Announces Series B Investment from Johnson & Johnson Development Corporation, Fletcher Spaght Ventures and Hatteras Venture Partners 10/24/2007 12:53:20 PM
Phase Bioscience, Inc. Strengthens Management Team 4/10/2007 12:28:37 PM
Phase Bioscience, Inc. Announces Investment From Johnson & Johnson (JNJ) Development Corporation 1/4/2007 10:58:34 AM
Phase Bioscience, Inc. Announces Licensing Agreement With Duke University 11/8/2006 11:07:41 AM